An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors. (Q44323240)
Jump to navigation
Jump to search
scientific article published in March 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors. |
scientific article published in March 2003 |
Statements
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors (English)
T Conroy
J F Seitz
S Gourgou
A Hua
D Mery-Mignard